// App-Quantinova.ai

M4221 2016 AHA : Clinical Effectiveness of Digoxin in Hospitalized Older Patients With Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Study of Medicare-Linked OPTIMIZE-HF

Researchers

Presenter

  • Apostolos Tsimploulis

Principal Investigators

  • Cherinne Arundel

  • Michael Zile

  • Richard Allman

  • Ali Ahmed

  • Marc Blackman

  • Charity Morgan

  • Javed Butler

  • Gregg C Fonarow

  • Prakash Deedwania

  • Michel White

  • wilbert S aronow

  • Gerasimos Filippatos

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • Stony Brook Univ, Sch of Nursing, Stony Brook, NY

  • Montreal Heart Institute, Montreal, Quebec, Canada

  • U of California San Francisco, Fresno, CA

  • Georgetown University, Washington, DC

  • University of California Los Angeles - David Geffen School of Medicine, Los Angeles, CA

  • Medcl Univ of South Carolina, Charleston, SC

  • MedStar Georgetown Univ/Washington Hosp Ctr, Washington, DC

  • University of Athens, Athens, Greece

  • Washington DC Veterans Affairs Medical Center, Washington, DC

  • New York Medical College Westchester Medical Center, Valhalla, NY

Locations

  • United States

  • Canada

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

  • Heart failure with preserved ejection fraction

Biomarkers

  • N/A

Drug/Treatment

  • Digoxin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved